Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for paltusotine, the first once-daily, oral ...
A recent study, published in JAMA Network Open, revealed that 29% of US adults are affected by absolute or functional iron deficiencies — and nearly one in three Americans may have an undiagnosed iron ...